Leaderboard

En | De
Sie sind hier: Onkologie » Urologische Tumoren 27. Mai 2026
Suchen
medline.ch
Urologische Tumoren
Erweiterte Suche
Dermatologie
Endokrinologie
Ernährung
Gastroenterologie
Gynäkologie
Hämatologie
Infektiologie
Kardiovaskuläre Erkrankungen
Muskuloskelettale Erkrankungen
Neurologie
Onkologie
Bewegungsapparat
Blut
Endokrine Organe
Gynäkologische Tumoren
Haut
Magen-Darm
ORL
Respirationstrakt
Urologische Tumoren
ZNS
Ophthalmologie
ORL
Pädiatrie
Psychiatrie
Respirationstrakt
Sportmedizin
Urologie-Nephrologie
Schrift: Schrift grösser Schrift kleiner

Rect Top
   Seite 1 von 8926  vorhergehende Seite nächste Seite
   
   Artikel 1 - 20 / 178505  
   
Androgen Receptor Pathway Inhibitors for Metastatic Hormone-Sensitive Prostate Cancer Outside of Randomized Controlled Trials: A Systematic Review and Meta-Analysis of Prognostic Factors in Real-World Analyses.
Clin Genitourin Cancer
Miyajima K, Yanagisawa T, Miszczyk M, Inoue S, Roessler N, Matsukawa A, Urabe F, Mori K, Karakiewicz PI, Chlosta P, Kimura T, Shariat SF.
PMID: 42191465 [PubMed - as supplied by publisher]


Urinary pH and oncologic outcomes after bacillus Calmette-Guérin in non-muscle invasive bladder cancer: A retrospective cohort study.
Actas Urol Esp (Engl Ed)
Kayar K, Kayar R, Ozdemir BB, Karabay E, Tosun C, Ozturk MI, Yucebas OE.
PMID: 42191064 [PubMed - as supplied by publisher]


Neoadjuvant Durvalumab ± Tremelimumab in Combination With Dose-Dense Methotrexate, Vinblastine, Doxorubicin, and Cisplatin in Muscle-Invasive Bladder Carcinoma: Results of the Phase I/II NEMIO Study.
J Clin Oncol
Thibault C, Bennamoun M, Fléchon A, Gravis G, Pouessel D, Combe P, Borchiellini D, Loriot Y, Laguerre B, Barthélémy P, Huillard O, Gross-Goupil M, Le Roy A, Jaffrelot L, Cancel M, Audenet F, Belhouari H, Kaci G, Lepicard E, Vernerey D, Henriques J, Oudard S.
PMID: 42190158 [PubMed - as supplied by publisher]


Efficacy, Safety, and Cost-Effectiveness of Reduced versus Full Initial Doses of Androgen Receptor Signaling Inhibitors in Non-Metastatic Castration-Resistant Prostate Cancer: A Multicenter Retrospective Study.
Prostate
Asanuma H, Fujita N, Kato S, Kawashima Y, Shinohara M, Tabata R, Yoneyama F, Tanaka R, Oishi T, Miura H, Togashi K, Okita K, Horiguchi H, Tanaka T, Noro D, Suzuki Y, Sato S, Ohyama C, Hatakeyama S.
PMID: 42190045 [PubMed - as supplied by publisher]


TTK Overexpression as a Prognostic Indicator and Immune Modulator in Kidney Renal Clear Cell Carcinoma.
Mol Carcinog
Singh A, Lakkaniga NR.
PMID: 42189826 [PubMed - as supplied by publisher]


Characteristics and outcome of congenital mesoblastic nephroma: A report of 376 patients registered in the SIOP 93-01, SIOP WT 2001, UK-IMPORT, and AIEOP protocols.
PLoS One
Quarello P, Dandis R, Chowdhury T, Verschuur A, Brok J, Vujanic G, Vokuhl C, Collini P, Coulomb A, Serra A, Biasoni D, Flores P, Kager L, Segers H, Mali, Burman MM, Dos Reis Farinha NJ, Romerius P, Godzinski J, van Grotel M, Ramirez-Villar GL, De Camargo B, Furtwängler R, Al-Saadi R, Van Tinteren H, Graf N, Spreafico F, van den Heuvel-Eibrink M.
PMID: 42189790 [PubMed - indexed for MEDLINE]


Integrative advances in biomarker-driven prostate cancer management from genomic discovery to precision oncology.
Discov Oncol
Ramesh P, Shree L, Balraj AS.
PMID: 42189429 [PubMed - as supplied by publisher]


The Role of Artificial Intelligence in the Characterization and Outcome Prediction of Prostate Cancer: A Systematic Review.
Tomography
Aljoudi S, Khan A, Dajani I, Al-Ani M, Mina M, Baroudi D, Al-Saffar S, Aouadi S, Torfeh T, Hammoud R, Al Hammadi N, Yousef MS.
PMID: 42188703 [PubMed - indexed for MEDLINE]


MRI-Derived Biomarkers and Radiomic Signatures for Early, Dose-Dependent Evaluation of Prostate Cancer Radiotherapy: An Exploratory Study.
J Imaging
Bekou E, Mulita A, Koukourakis IM, Courcoutsakis N, Kotini A, Psatha E, Tsakaldimis G, Seimenis I, Koukourakis MI, Karavasilis E.
PMID: 42188250 [PubMed]


Ruptured Wilms Tumor: Clinical Features, Diagnostic Challenges, and Survival Outcomes.
Curr Oncol
Emadeldeen H, Ghandour K, Al-Shamaileh T, Ibrahimi AK, Sarhan N, Sultan I, Halalsheh H.
PMID: 42187610 [PubMed - indexed for MEDLINE]


Prostate Cancer Biomarkers with a Focus on Galectin-3: Emerging Clinical and Therapeutic Implications.
Curr Oncol
Narvel H, Ganiyani MA, Gulam Nabi A, Goyal A, Garje R, Srinivasan S, Ahmed H, Kilari D.
PMID: 42187597 [PubMed - indexed for MEDLINE]


Forecasting Trends in Androgen Deprivation Therapy Intensification for Metastatic Hormone-Sensitive Prostate Cancer: A Retrospective Population-Based Cohort and Time-Series Analysis.
Curr Oncol
Khosh Kish E, Dvorani E, Saskin R, Wilton AS, Satkunasivam R, Aminoltejari K, Hird A, Berscheid K, Roy S, Morgan SC, Ong M, Jiang DM, Gotto GT, Shayegan B, Kulkarni GS, Breau RH, Lalani AA, Nguyen DD, Wallis CJD.
PMID: 42187593 [PubMed - indexed for MEDLINE]


Diagnostic and prognostic value of lncSPATA8-AS1 in prostate cancer and its regulatory effect on tumor progression.
Cancer Biol Ther
Zhong J, Deng Y, Qin X, Yang Q.
PMID: 42187002 [PubMed - indexed for MEDLINE]


Bladder-sparing chemoradiotherapy following neoadjuvant chemotherapy for muscle-invasive bladder cancer: a retrospective cohort study.
BMC Urol
Mofid B, Jafari A, Simforoosh N, Basiri A, Siavashpour M, Siavashpour Z, Zabihi MS, Ghajari M, Razzaghdoust A.
PMID: 42185887 [PubMed - as supplied by publisher]


Overdiagnosis in renal cancer: the hidden consequence of modern imaging.
Int Urol Nephrol
Vallecilla Valencia K, Garcia-Perdomo HA.
PMID: 42185723 [PubMed - as supplied by publisher]


ASO Author Reflections: Refining CT Heterogeneity Scoring to Improve Clear Cell Renal Cell Carcinoma Diagnosis in Small Renal Masses.
Ann Surg Oncol
Zhang W, Li X, Zhu X, Song X, Qu J.
PMID: 42185708 [PubMed - as supplied by publisher]


Impact of frailty on perioperative and oncologic outcomes after robotic radical prostatectomy: a multicenter study with competing risk analysis.
J Robot Surg
Rabie A, Dovey Z, Falavolti C, Papalia R, Signore S, Martini A, Marco MD, Balah A, Petitti T, Buscarini M, Zaytoun O.
PMID: 42185689 [PubMed - indexed for MEDLINE]


Multi-omics analysis reveals TM4SF19 as a diagnostic and prognostic biomarker in bladder cancer.
Discov Oncol
Aizezi X, Silafu B, Shi H, Huang J.
PMID: 42185687 [PubMed - as supplied by publisher]


Preoperative lung immune prognostic index (LIPI) predicts postoperative outcomes in clear cell renal cell carcinoma: a multicenter study.
Sci Rep
Pan Z, Li Y, Lou J, Shan S, Guo Y, Jiang S, He Q, Zhou G, Yang L.
PMID: 42185427 [PubMed - as supplied by publisher]


Pembrolizumab plus high-dose IL-2 in advanced clear cell renal cell carcinoma: six-year survival outcomes and molecular signatures from a phase 2 trial.
Nat Commun
Johnson JS, Miller JW, Hatoum F, Schell MJ, Yu X, Roman Souza G, Mizelle S, Gullapalli K, Fazili A, Jain R, Chatzkel J, Cen L, Dhillon J, Cubitt C, Yao J, Whiting J, Li J, Swank J, Jameel G, Zhang J, Wang X, Spiess PE, Fishman M, Chahoud J.
PMID: 42185255 [PubMed - as supplied by publisher]


   
   Artikel 1 - 20 / 178505    Seite 1 von 8926  vorhergehende Seite nächste Seite

 
Rect Bottom
Adserver Footer
 

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

 

Übersetzungsproblem?

mehr >>

  Zeitfenster  
   

Sky right 1